B
Bryan Burmeister
Researcher at Princess Alexandra Hospital
Publications - 163
Citations - 8693
Bryan Burmeister is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 39, co-authored 158 publications receiving 7908 citations. Previous affiliations of Bryan Burmeister include Sir Charles Gairdner Hospital & University of Queensland.
Papers
More filters
Journal ArticleDOI
Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05).
Daniel E. Roos,S. Davis,Sandra Turner,Peter C. O'Brien,Nigel Spry,Bryan Burmeister,Peter Hoskin,David Ball +7 more
TL;DR: Only one patient was found conclusively not to have genuine neuropathic pain, and there were no detected 'geographical misses' with RT fields, in Trans-Tasman Radiation Oncology Group 96.05.
Journal ArticleDOI
Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.
Julie Winstanley,Julie Winstanley,Teresa Young,Frances M. Boyle,Frances M. Boyle,Mia Bergenmar,Andrew Bottomley,Bryan Burmeister,Luca Giovanni Campana,Jennifer Garioch,Madeleine King,Dejan Nikolic,Lonneke V. van de Poll-Franse,Robyn P. M. Saw,John F. Thompson,Edward White +15 more
TL;DR: It is shown that melanoma patients have important QoL issues that have been incorporated into a new cross-culturally validated instrument that will aid future decision-making in the management and clinical trials of this complex group of patients.
Journal ArticleDOI
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality
Gerald B Fogarty,Angela Hong,Kari Dolven-Jacobsen,Claudius H Reisse,Bryan Burmeister,Lauren H Haydu,Haryana M. Dhillon,Victoria Steel,Brindha Shivalingam,Kate Drummond,Janette L. Vardy,Anna K. Nowak,Anna K. Nowak,George Hruby,George Hruby,Richard A. Scolyer,Richard A. Scolyer,Catherine Mandel,John F. Thompson +18 more
TL;DR: The data provision and quality to date indicates that a reliable outcome will be obtained when the final analysis is performed, and the Data Safety Monitoring Committee (DSMC) recommended the trial continue recruitment after reviewing the unblinded data.
Journal ArticleDOI
A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer.
Bryan Burmeister,Euan Walpole,Nancy D’Arcy,Elizabeth Burmeister,Sharon Cox,Damien Thomson,Jennifer Harvey,B. Mark Smithers +7 more
TL;DR: Although weekly oxaliplatin in combination with infusional 5 fluorouracil produces durable remissions in esophageal cancer, the regimen used in this trial was not acceptable for routine use.
Journal ArticleDOI
Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma
David Pryor,Elizabeth Burmeister,Elizabeth Burmeister,Bryan Burmeister,Bryan Burmeister,Michael Poulsen,Sandro V. Porceddu,Sandro V. Porceddu +7 more
TL;DR: The combination of cetuximab and low doses of RT to the anterior oral cavity has resulted in a distinctive pattern of cheilitis and anterior stomatitis in patients, and further exploration of this phenomenon may yield additional insights into the interaction of cetusimab with RT in non-target tissues.